TrialDiabetes technology & therapeutics2024

Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes.

Carol J Levy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.